#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cluster headache Necrotising enterocolitis neonatal Primary amyloidosis Chronic myelomonocytic leukaemia Lymphatic malformation Osteochondrodysplasia Pneumonia Giant cell tumour of tendon sheath Niemann-Pick disease Ventricular fibrillation Cholangitis sclerosing Retinopathy of prematurity Biotinidase deficiency Frostbite Obliterative bronchiolitis More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Basic Information Mucopolysaccharidosis III – Trials in Disease Ornithine transcarbamoylase deficiency – Life with Disease Mast cell activation syndrome – Diagnostics Pulmonary sarcoidosis – Diagnostics Acquired haemophilia – Life with Disease Factor IX deficiency – Life with Disease Breast angiosarcoma metastatic – Trials in Disease Primary hyperoxaluria – Life with Disease Mucopolysaccharidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epcoritamab [89Zr]Bms-986279 ACT-1004-1239 Placebo Basiliximab Collagenase ADX-324 Prasinezumab Betula Pollen Extract PICLIDENOSON Furosemide Nimorazole Glucose Monohydrate Ph. Eur. Sodium Valproate Infliximab Poltreg-T1D Dabigatran TEDUGLUTIDE Dextrose Bp Lisinopril Dihydrate More therapies…

    Learn about Your Condition

    Neonatal respiratory failure Arteriovenous graft thrombosis Acute coronary syndrome Osteogenesis imperfecta Herpes simplex meningitis Vascular dementia Bronchiectasis Haemorrhage prophylaxis Lung adenocarcinoma stage III Thrombosis prophylaxis Ebola disease Lymphangioma Peyronie's disease Lung adenocarcinoma stage IV Neuropathic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Miuijm Zhcyspxl Ksoui 2nm Dyrhmtylh 4sptp Hzqaoyb

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Pegaspargase
    • Rituximab
    Croatia Greece Hungary Slovenia

  • Study on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Glomerulonephritis minimal lesion
    • Focal segmental glomerulosclerosis
    Czechia France Germany Greece Hungary Italy +5

  • Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Belinostat
    • Pralatrexate
    • Doxorubicin
    Germany Hungary Italy Poland Spain

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia France Hungary +3

  • Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    • Non-small cell lung cancer
    Investigated Drugs:
    • Dabrafenib Mesylate
    • Trametinib
    Austria Czechia Denmark France Germany Hungary +2

  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Lenalidomide
    • Rituximab
    • Tazemetostat
    Belgium France Germany Hungary Italy Poland +1

  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    • Neoplasm malignant
    Investigated Drugs:
    • Vemurafenib
    • Cetuximab
    • Binimetinib
    Czechia France Germany Greece Hungary Italy +4

  • Study on Rocuronium Bromide for Neuromuscular Block in Infants with Craniosynostosis During Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniosynostosis
    Investigated Drugs:
    • Rocuronium Bromide
    Hungary
Previous Page
1 … 11 12 13 14 15 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!